Boston Scientific Corporation (BSX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Boston Scientific Corpora...

    NYSE: BSX · Real-Time Price · USD
    105.24
    -2.85 (-2.64%)
    At close: Sep 10, 2025, 3:59 PM
    105.68
    0.42%
    After-hours: Sep 10, 2025, 07:59 PM EDT

    Boston Scientific Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 16.75B 14.24B 12.68B 11.89B
    Cost of Revenue
    		 6.48B 5.41B 4.97B 4.43B
    Gross Profit
    		 10.27B 8.83B 7.71B 7.46B
    Operating Income
    		 2.63B 2.18B 1.82B 1.92B
    Interest Income
    		 107M 22M 10M 4M
    Pretax Income
    		 2.28B 1.99B 1.14B 1.08B
    Net Income
    		 1.85B 1.59B 698M 1.04B
    Selling & General & Admin
    		 5.98B 5.19B 4.52B 4.29B
    Research & Development
    		 1.61B 1.41B 1.32B 1.2B
    Other Expenses
    		 33M 46M 47M 49M
    Operating Expenses
    		 7.63B 6.65B 5.89B 5.54B
    Interest Expense
    		 387M 272M 464M 349M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 14.11B 12.06B 10.86B 9.97B
    Income Tax Expense
    		 436M 393M 443M 36M
    Shares Outstanding (Basic)
    		 1.47B 1.45B 1.43B 1.42B
    Shares Outstanding (Diluted)
    		 1.49B 1.46B 1.44B 1.43B
    EPS (Basic)
    		 1.26 1.08 0.45 0.69
    EPS (Diluted)
    		 1.25 1.07 0.45 0.69
    EBITDA
    		 3.94B 3.45B 2.74B 2.52B
    EBIT
    		 2.67B 2.26B 1.6B 1.43B
    Depreciation & Amortization
    		 1.27B 1.2B 1.14B 1.09B

    Add to Watchlist